FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20201014E00006
1. Date of relevant event: 14/10/2020
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02552
4. Name of listed corporation: Hua Medicine - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 1,054,893,800
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Lin
(Other names) George Chien Cheng
10. Name of director (Chinese): 林潔誠 
11. Chinese Character Code as printed on HKID Card: 265133816134
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1316There has been a change in nature of your interest in the shares because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
 
2101Beneficial owner
 
2101Beneficial owner
 		 154,646  HKD       
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position34,391,7003.26
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position34,391,7003.26
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2305Beneficiary of a trust (other than a discretionary interest)
Long position3,633,178
2101Beneficial owner
Long position30,758,522
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4105Unlisted derivatives - Physically settled
30/09/201802/04/2028USD0USD0.467  7,034,975
Long position
4105Unlisted derivatives - Physically settled
22/12/201802/04/2028USD0USD0.467  18,557,430
Long position
4105Unlisted derivatives - Physically settled
14/09/201813/09/2022USD0USD0.000  3,556,825
Long position
4105Unlisted derivatives - Physically settled
23/01/202007/03/2029HKD0HKD8.866  300,000
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
   
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
The George and Ann Lin 2005 TrustAddresses of individuals are not displayed.
5102Beneficiary of a trust (other than a discretionary interest)
Long position3,633,178
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: The Director is entitled to 154,646 Shares pursuant to the vesting of restricted stock units on 14 October 2020 under the Pre-IPO Share Incentive Scheme.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 14/10/2020
(dd/mm/yyyy)